ID: ALA3347627

Max Phase: Preclinical

Molecular Formula: C42H50BN5O5

Molecular Weight: 715.70

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1cnccn1)B1O[C@@H]2[C@H]3CC[C@H](C3(C)C)[C@]2(C)O1

Standard InChI:  InChI=1S/C42H50BN5O5/c1-26(2)21-36(43-52-37-31-17-18-35(41(31,3)4)42(37,5)53-43)48-39(50)32(23-27-11-7-6-8-12-27)46-38(49)33(47-40(51)34-25-44-19-20-45-34)24-28-15-16-29-13-9-10-14-30(29)22-28/h6-16,19-20,22,25-26,31-33,35-37H,17-18,21,23-24H2,1-5H3,(H,46,49)(H,47,51)(H,48,50)/t31-,32+,33+,35-,36+,37-,42+/m1/s1

Standard InChI Key:  UCRIGFMMGLHGLL-WXCTUJBXSA-N

Associated Targets(Human)

Proteasome subunit beta type-7 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Proteasome Macropain subunit MB1 2451 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 715.70Molecular Weight (Monoisotopic): 715.3905AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Trippier PC, McGuigan C.  (2010)  Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications,  (3): [10.1039/C0MD00119H]

Source